• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.

作者信息

Lerchenfeldt S M, Cronin S M, Chandrasekar P H

机构信息

Department of Pharmacy, Wayne State University College of Pharmacy and Allied Health, Detroit, Michigan, USA; Karmanos Cancer Center, Detroit, Michigan, USA.

出版信息

Transpl Infect Dis. 2013 Dec;15(6):634-8. doi: 10.1111/tid.12110. Epub 2013 Jul 25.

DOI:10.1111/tid.12110
PMID:23890163
Abstract

BACKGROUND

The Karmanos Cancer Center Bone Marrow Transplant (KCC BMT) Center updated the vaccination protocol for transplant patients based on joint guidelines recently published by European Bone Marrow Transplantation, Centers for Disease Control, Infectious Diseases Society of America, and the American Society for Bone Marrow Transplantation. The objectives for this study were to determine the impact of vaccination cards and telephone outreach on vaccine adherence and to determine the reasons for missed or delayed vaccinations.

METHODS

Retrospective analysis consisted of autologous and allogeneic hematopoietic stem cell transplant (HSCT) patients at the KCC BMT Clinic who received vaccines based on the guidelines published in 2009. Adherence was calculated as percentage of vaccines missed over the vaccination period.

RESULTS

Overall, 37 of 111 patients (33%) missed at least 1 vaccine set and 29 patients (26%) received 1 set later than recommended. Reasons for missed and delayed vaccines included neutropenia/thrombocytopenia, anticoagulation, active infection, and graft-versus-host complications.

CONCLUSIONS

Current guidelines recommend a complex vaccination schedule for the HSCT recipients, which may lead to difficulties with adherence. Our study shows that missed and delayed vaccinations are common in both autologous and allogeneic HSCT recipients. Methods to improve adherence are needed.

摘要

相似文献

1
Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.
Transpl Infect Dis. 2013 Dec;15(6):634-8. doi: 10.1111/tid.12110. Epub 2013 Jul 25.
2
[Vaccination].[疫苗接种]
Klin Padiatr. 2001 Sep;213 Suppl 1:A77-83. doi: 10.1055/s-2001-17503.
3
Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium.儿童血液和骨髓移植协会造血干细胞移植后的免疫接种实践。
Pediatr Blood Cancer. 2010 Jul 1;54(7):970-5. doi: 10.1002/pbc.22444.
4
Revaccination of bone marrow transplant recipients: a review of current practices in Australia.骨髓移植受者的再次接种:澳大利亚当前实践综述
Intern Med J. 2009 Apr;39(4):216-21. doi: 10.1111/j.1445-5994.2009.01698.x.
5
Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.自体外周血干细胞移植受者和骨髓移植受者在移植后两年内接种疫苗后的抗体反应相似。
Bone Marrow Transplant. 2001 Oct;28(8):775-81. doi: 10.1038/sj.bmt.1703239.
6
Secondary failure of platelet recovery after hematopoietic stem cell transplantation.造血干细胞移植后血小板恢复的继发性失败。
Biol Blood Marrow Transplant. 2001;7(3):154-62. doi: 10.1053/bbmt.2001.v7.pm11302549.
7
Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.加拿大造血干细胞移植后巨细胞病毒的预防与治疗:当前实践描述及与美国疾病控制中心/美国传染病学会/美国血液和骨髓移植学会指南建议的比较
Biol Blood Marrow Transplant. 2004 May;10(5):287-97. doi: 10.1016/j.bbmt.2003.10.007.
8
Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.造血干细胞移植后持续性孤立性血小板减少症:形态学相关性
Bone Marrow Transplant. 1998 Dec;22(11):1071-6. doi: 10.1038/sj.bmt.1701499.
9
Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.异基因造血干细胞移植受者的接种疫苗:慢性移植物抗宿主病临床实践国际共识会议报告。
Vaccine. 2011 Apr 5;29(16):2825-33. doi: 10.1016/j.vaccine.2011.02.018. Epub 2011 Feb 20.
10
Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.患有感染并发症的造血干细胞移植受者中的氟喹诺酮耐药性
Biomed Pharmacother. 2005 Oct;59(9):511-6. doi: 10.1016/j.biopha.2005.06.008. Epub 2005 Sep 23.

引用本文的文献

1
Quality Improvement Initiative to Improve Time and Adherence to Revaccination after Hematopoietic Cell Transplantation: Implementation of a Revaccination Clinic within the Transplantation Program.提高造血细胞移植后疫苗复种及时性和依从性的质量改进措施:在移植项目中实施疫苗复种门诊。
Transplant Cell Ther. 2023 Oct;29(10):635.e1-635.e8. doi: 10.1016/j.jtct.2023.07.020. Epub 2023 Jul 28.
2
Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000-2015.器官移植受者中的法定传染病:一项数据关联队列研究,2000 - 2015年
Open Forum Infect Dis. 2022 Aug 3;9(8):ofac337. doi: 10.1093/ofid/ofac337. eCollection 2022 Aug.
3
Quality improvement initiative to improve revaccination rates after autologous stem cell transplantation.
提高自体干细胞移植后再次接种疫苗率的质量改进举措。
BMJ Open Qual. 2022 Jun;11(2). doi: 10.1136/bmjoq-2021-001802.
4
Hospitalizations for vaccine-preventable infections among pediatric hematopoietic cell transplantation recipients in the first 5 years after transplantation.移植后 5 年内儿科造血细胞移植受者疫苗可预防感染的住院治疗情况。
Bone Marrow Transplant. 2021 Nov;56(11):2656-2663. doi: 10.1038/s41409-021-01373-z. Epub 2021 Jun 21.
5
Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.异基因和自体造血干细胞移植患者移植后疫苗接种的比较:单中心质量分析。
Bone Marrow Transplant. 2021 Jul;56(7):1717-1719. doi: 10.1038/s41409-021-01240-x. Epub 2021 Mar 1.
6
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.异基因造血干细胞移植后流感疫苗接种的临床效果:一项横断面、前瞻性、观察性研究。
Clin Infect Dis. 2019 May 17;68(11):1894-1903. doi: 10.1093/cid/ciy792.
7
Difficulties in the revaccination program of hematopoietic stem cell transplantation recipients.造血干细胞移植受者再次接种疫苗计划中的困难。
Rev Inst Med Trop Sao Paulo. 2017 Nov 6;59:e69. doi: 10.1590/S1678-9946201759069.
8
Live virus vaccines in transplantation: friend or foe?移植中的活病毒疫苗:是友还是敌?
Curr Infect Dis Rep. 2015 Apr;17(4):472. doi: 10.1007/s11908-015-0472-y.